NCT06393738 2026-02-10A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.Arvinas Inc.Phase 1 Recruiting255 enrolled
NCT04234048 2025-09-22Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin LymphomaSciTech Development, Inc.Phase 1 Recruiting46 enrolled
NCT04480788 2021-01-06CD7-CART in the Treatment of r / r CD7 Positive Hemolymph System Malignancies on Increasing Dose and Open Label StudyPersonGen BioTherapeutics (Suzhou) Co., Ltd.Phase 1 Unknown9 enrolled
NCT00697346 2019-05-31Study of MLN8237 in Participants With Advanced Hematological MalignanciesTakedaPhase 1 Completed58 enrolled 52 charts
NCT00293488 2016-06-23SL-11047 in Treating Patients With Relapsed or Refractory LymphomaProgen PharmaceuticalsPhase 1 Completed20 enrolled
NCT01748721 2016-01-08MORAb-004 in Treating Young Patients With Recurrent or Refractory Solid Tumors or LymphomaMorphotekPhase 1 Completed27 enrolled